Clinical Trial

Triple-Modal Therapy in Early-Stage Femoral Head Osteonecrosis (TM-ONFH)

Study acronym: TM-ONFH
Completed
View on ClinicalTrials.gov →
Summary
This retrospective observational study evaluates the clinical and radiological outcomes of patients with early-stage osteonecrosis of the femoral head treated with a combination of core decompression, stromal vascular fraction (SVF), and hyperbaric oxygen therapy (HBOT). A total of 24 patients were included and followed for two years. The aim of this study is to assess the effectiveness of this combined therapeutic approach in improving clinical outcomes and preventing disease progression.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-24.
Trial Details
NCT Number NCT07560163
Lead Sponsor Ankara City Hospital Bilkent
Conditions Osteonecrosis of the Femoral Head
Enrollment 24 participants
Start Date 2025-01-22
Primary Completion 2025-09-22 (estimated)
Study Completion 2025-11-22 (estimated)
Updated on ClinicalTrials.gov 2026-05-06